Biohit oyj’s annual general meeting 2020
Stock Exchange Release
Biohit takes the threat of the Corona virus extremely seriously as a company which promotes healthy of the people. Biohit has, based on the development of the situation and the announcement by the Finnish Government decided to convene the Annual General Meeting at a later stage when Corona virus does not anymore cause any healthyrisks for for the meeting participants.
Helsinki, 27 March 2020
Board of Directors
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com